Aerie Pharmaceuticals Patents – Insights & Stats (Updated 2023)

Aerie Pharmaceuticals has a total of 334 patents globally, out of which 143 have been granted. Of these 334 patents, more than 73% patents are active. The USA is where Aerie Pharmaceuticals has filed the maximum number of patents, followed by Europe (EPO) and Australia. Parallelly, the USA seems to be the main focused R&D center of Aerie Pharmaceuticals and is also the origin country of the firm.

Aerie Pharmaceuticals was founded in the year 2005 by David L. Epstein and Casey C. Kopczynski. Company is a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of therapies for the treatment of patients with glaucoma and other diseases of the eye.

Do read about some of the most popular patents of Aerie Pharmaceuticals which have been covered by us in this article and also you can find Aerie Pharmaceuticals patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Aerie Pharmaceuticals patent portfolio.

How many patents does Aerie Pharmaceuticals have?

Aerie Pharmaceuticals has a total of 334 patents globally. These patents belong to 67 unique patent families. Out of 334 patents, 244 patents are active.

How Many Patents did Aerie Pharmaceuticals File Every Year?

Aerie Pharmaceuticals Patent Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantAerie Pharmaceuticals Applications FiledAerie Pharmaceuticals Patents Granted
2022176
20212423
20202824
20195412
20181912
2017343
2016249
2015138
20143016
201327
201222
201131

How many Aerie Pharmaceuticals patents are Alive/Dead?

Worldwide Patents

Aerie Pharmaceuticals Patent Portfolio

How Many Patents did Aerie Pharmaceuticals File in Different Countries?

Aerie Pharmaceuticals Worldwide Patent Filing

List of Countries in which Aerie Pharmaceuticals Filed Patents

CountryPatents
United States Of America87
Europe34
Australia33
Canada23
Hong Kong (S.A.R.)15
China15
Germany15
Spain14
Austria12
Korea (South)10
Mexico7
India7
Singapore6
Brazil6
Italy4
Netherlands2
Hungary1
Portugal1
Finland1
Denmark1
Israel1
Norway1
Poland1

Where are Research Centres of Aerie Pharmaceuticals Patents Located?

R&D Centres of Aerie Pharmaceuticals

10 Best Aerie Pharmaceuticals Patents

US20070135499A1 is the most popular patent in the Aerie Pharmaceuticals portfolio. It has received 66 citations so far.

Below is the list of 10 most cited patents of Aerie Pharmaceuticals:

Publication NumberCitation Count
US20070135499A166
US7671205B260
US20090069371A158
US20120135984A156
US20100093790A156
US20070254920A155
US7470787B252
US8394826B250
US8716310B249
US8034943B249

What are Aerie Pharmaceuticals key innovation segments?

What Technologies are Covered by Aerie Pharmaceuticals?

The chart below distributes patents filed by Aerie Pharmaceuticals in different countries on the basis of the technology protected in patents. It also represents the markets where Aerie Pharmaceuticals thinks it’s important to protect particular technology inventions.

R&D Focus: How has Aerie Pharmaceuticals search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Aerie Pharmaceuticals?

Related Articles

Celcem Patents – Insights & Stats (Updated 2024)

Celcem has a total of 28 patents globally, out of which all patents have been granted. Of these 28 patents, all patents patents are active. Singapore is where Celcem has filed the maximum number of patents. Parallelly, Singapore seems to be the main focused R&D centre and also is the

Read More »

Was this article helpful?

Leave a Comment

Fill the form to get the details:

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.